Detalhe da pesquisa
1.
Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis.
Connect Tissue Res
; 54(3): 187-96, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23586407